ACUVAIL Trademark

Trademark Overview

On Friday, September 5, 2008, a trademark application was filed for ACUVAIL with the United States Patent and Trademark Office. The USPTO has given the ACUVAIL trademark a serial number of 77563589. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, December 4, 2019. This trademark is owned by Allergan, Inc.. The ACUVAIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for ophthalmic use, namely, prostaglandin inhibitors
acuvail

General Information

Serial Number77563589
Word MarkACUVAIL
Filing DateFriday, September 5, 2008
Status800 - REGISTERED AND RENEWED
Status DateWednesday, December 4, 2019
Registration Number3703125
Registration DateTuesday, October 27, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for ophthalmic use, namely, prostaglandin inhibitors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 9, 2008
Primary Code005
First Use Anywhere DateFriday, September 5, 2008
First Use In Commerce DateFriday, August 14, 2009

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Wednesday, December 4, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, December 4, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 4, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 4, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 22, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 22, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, October 27, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, January 4, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, January 4, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, January 4, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 12, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 12, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 27, 2009REGISTERED-PRINCIPAL REGISTER
Friday, September 18, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, September 14, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 14, 2009STATEMENT OF USE PROCESSING COMPLETE
Monday, August 17, 2009USE AMENDMENT FILED
Monday, September 14, 2009EXTENSION 1 GRANTED
Monday, August 17, 2009EXTENSION 1 FILED
Monday, September 14, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 17, 2009TEAS EXTENSION RECEIVED
Monday, August 17, 2009TEAS STATEMENT OF USE RECEIVED
Tuesday, March 10, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 16, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 26, 2008NOTICE OF PUBLICATION
Monday, November 10, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 10, 2008ASSIGNED TO LIE
Tuesday, November 4, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 3, 2008ASSIGNED TO EXAMINER
Tuesday, September 9, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

acuvail prostaglandin inhibitors namely ophthalmic preparations pharmaceutical